Protalix Resubmits To FDA The BLA For Pegunigalsidase Alfa For Treatment Of Fabry Disease

RTTNews | hace 1093
Protalix Resubmits To FDA The BLA For Pegunigalsidase Alfa For Treatment Of Fabry Disease

(RTTNews) - Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Monday the resubmission on Wednesday of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for PRX-102 (pegunigalsidase alfa) for the treatment of adult patients with Fabry disease.

Pegunigalsidase alfa is a purposefully-designed, long-acting recombinant, PEGylated, cross-linked a-galactosidase-A investigational product candidate.

The BLA resubmission includes a comprehensive set of clinical and manufacturing data, which was compiled from studies that involved more than 140 Fabry disease patients with up to five years of follow up including all three completed studies in the PRX-102 Phase III clinical program.

The BLA resubmission also includes safety data compiled from the ongoing phase III extension studies of PRX-102. If approved, Protalix will be eligible to receive a milestone payment from Italian pharmaceutical company Chiesi Farmaceutici S.p.A. upon BLA approval.

Protalix and Chiesi anticipate that the FDA will complete its review of the resubmission within six months of receipt.

The European Medicines Agency (EMA) is currently reviewing the marketing authorization application for PRX-102, and interactions with the EMA are ongoing.

For More Such Health News, visit rttnews.com

read more
Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending marketing authorization for PRX-102 (pegunigalsidase alfa), the first and only pegylated enzyme for the treatment of adult patients with Fabry disease.
RTTNews | hace 991
Bay Street May Open Higher Again

Bay Street May Open Higher Again

Canadian stocks may open higher on Tuesday, riding on firm commodity prices. The passage of a short-term funding bill late Monday to end the longest government shutdown in U.S. history, is likely to aid sentiment.
RTTNews | hace 4h 20min
UK Unemployment Rate Highest Since 2021

UK Unemployment Rate Highest Since 2021

The UK unemployment rate increased to the highest since early 2021 in the third quarter, raising chances of an interest rate cut, official data revealed on Tuesday. The ILO jobless rate rose to 5.0 percent in the third quarter from 4.8 percent in the three months to August, the Office for National Statistics said. The rate was above economists' forecast of 4.9 percent.
RTTNews | hace 5h 15min
FTSE 100 Rises On Rate Cut Hopes; Vodafone Group Moves Up Sharply

FTSE 100 Rises On Rate Cut Hopes; Vodafone Group Moves Up Sharply

U.K.'s FTSE 100 index has moved up sharply on Tuesday, amid hopes of a rate cut by the Bank of England next month after data showed an increase in the nation's unemployment rate in the third quarter. The passage of a short-term funding bill late Monday to end the longest government shutdown in U.S. history is also aiding sentiment.
RTTNews | hace 5h 32min
CAC 40 Up 0.6%; Hermes International, LVMH Among Top Gainers

CAC 40 Up 0.6%; Hermes International, LVMH Among Top Gainers

French stocks are up firmly in positive territory on Tuesday, extending gains from the previous session, following the passage of a short-term funding bill late Monday to end the longest government shutdown in U.S. history.
RTTNews | hace 5h 59min
German Economic Confidence Weakens In November

German Economic Confidence Weakens In November

German economic confidence weakened moderately in November as investors became concerned about the ability of economic policies to address its key issues, a monthly survey conducted by the think tank ZEW showed Tuesday. The economic sentiment index fell unexpectedly to 38.5 in November from 39.3 in the previous month. The reading was forecast to rise to 41.0.
RTTNews | hace 6h 56min